Sanofi | SNY - Ebitda


Sanofi reported EUR2.72B in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
AbbVie USD 6.91B 3.22B Jun/2026
Amgen USD 3.86B 1.28B Mar/2026
AstraZeneca USD 7.46B 2.3B Sep/2026
Bristol-Myers Squibb USD 3.48B 1.6B Sep/2026
Canopy Growth CAD -137M 134.13M Mar/2026
Corcept Therapeutics USD -49M 53.2M Mar/2026
Drreddys Laboratories INR 8.63B 12.96B Mar/2026
Eli Lilly USD 9.46B 3.54B Sep/2026
Genmab DKK 401M 186M Jun/2026
GlaxoSmithKline GBP 3.51B 734M Jun/2026
Glaxosmithkline GBP 2.77B 1.98B Mar/2026
J&J USD 8.99B 721M Jun/2026
Lakefront Biotherapeutics EUR -63.7M 624.2M Mar/2026
Merck USD 1.42B 2.97B Jun/2026
Novartis USD 8.62B 2.14B Sep/2026
Novartis USD 5.41B 431M Mar/2026
Pacira USD 48.67M 8.43M Jun/2026
Perrigo USD 141.6M 1.34B Mar/2026
Pfizer USD 6.01B 18M Jun/2026
Phibro Animal Health USD 68.1M 6.2M Dec/2025
Prestige Brands USD 61.24M 23.31M Jun/2026
Roche Holding CHF 13.43B 744M Jun/2026
Sanofi EUR 3.69B 375M Jun/2026
Sanofi EUR 2.72B 2.94B Mar/2026
Supernus Pharmaceuticals USD 55.6M 24M Sep/2026
UCB EUR 1.6B 570M Dec/2025
Zoetis USD 939M 0 Mar/2026